{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:29:11Z","timestamp":1754108951650,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12012-019-09533-w","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T08:02:53Z","timestamp":1559894573000},"page":"49-57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Action Potential Triangulation Explains Acute Proarrhythmic Effect of Aliskiren in a Whole-Heart Model of Atrial Fibrillation"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9172-296X","authenticated-orcid":false,"given":"Christian","family":"Ellermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Mittelstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Wolfes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Willy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Leitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Reinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit","family":"Frommeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"key":"9533_CR1","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/europace\/euw295","volume":"18","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., et al. (2016). 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace,18, 1609\u20131678.","journal-title":"Europace"},{"key":"9533_CR2","first-page":"CD007066","volume":"4","author":"VM Musini","year":"2017","unstructured":"Musini, V. M., Lawrence, K. A., Fortin, P. M., Bassett, K., & Wright, J. M. (2017). Blood pressure lowering efficacy of renin inhibitors for primary hypertension. Cochrane Database Systematic Review,4, CD007066.","journal-title":"Cochrane Database Systematic Review"},{"key":"9533_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00380-016-0874-2","volume":"32","author":"A Satoh","year":"2017","unstructured":"Satoh, A., Niwano, S., Niwano, H., Kishihara, J., Aoyama, Y., Oikawa, J., et al. (2017). Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation. Heart and Vessels,32, 90\u2013100.","journal-title":"Heart and Vessels"},{"key":"9533_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00395-011-0206-8","volume":"106","author":"C-F Tsai","year":"2011","unstructured":"Tsai, C.-F., Chen, Y.-C., Lin, Y.-K., Chen, S.-A., & Chen, Y.-J. (2011). Electromechanical effects of the direct renin inhibitor (aliskiren) on the pulmonary vein and atrium. Basic Research in Cardiology,106, 979\u2013993.","journal-title":"Basic Research in Cardiology"},{"key":"9533_CR5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00210-016-1249-z","volume":"389","author":"Z Zhao","year":"2016","unstructured":"Zhao, Z., Chen, Y., Li, W., Wang, X., Li, J., Yang, W., et al. (2016). Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine model. Naunyn Schmiedebergs Arch Pharmacol,389, 863\u2013871.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"9533_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10557-014-6509-x","volume":"28","author":"Z Zhao","year":"2014","unstructured":"Zhao, Z., Wang, X., Li, J., Yang, W., Cheng, L., Chen, Y., et al. (2014). Protective effects of aliskiren on atrial ionic remodeling in a canine model of rapid atrial pacing. Cardiovascular Drugs and Therapy,28, 137\u2013143.","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"9533_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/cvr\/cvv248","volume":"109","author":"C Yamada","year":"2015","unstructured":"Yamada, C., Kuwahara, K., Yamazaki, M., Nakagawa, Y., Nishikimi, T., Kinoshita, H., et al. (2015). The renin\u2013angiotensin system promotes arrhythmogenic substrates and lethal arrhythmias in mice with non-ischaemic cardiomyopathy. Cardiovascular Research,109, 162\u2013173.","journal-title":"Cardiovascular Research"},{"key":"9533_CR8","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.3760\/cma.j.issn.0366-6999.20130338","volume":"126","author":"Y-Y Jia","year":"2013","unstructured":"Jia, Y.-Y., Bao, Z.-W., Wei, M.-F., Zhu, J.-H., & Le, G. (2013). Aliskiren ameliorates sympathetic nerve sprouting and suppresses the inducibility of ventricular tachyarrhythmia in postinfarcted rat heart. Chinese Medical Journal (England),126, 4707\u20134714.","journal-title":"Chinese Medical Journal (England)"},{"key":"9533_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ijcard.2017.01.106","volume":"236","author":"G Frommeyer","year":"2017","unstructured":"Frommeyer, G., Kohnke, A., Ellermann, C., Dechering, D. G., Kochh\u00e4user, S., Reinke, F., et al. (2017). Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart model. International Journal of Cardiology,236, 423\u2013426.","journal-title":"International Journal of Cardiology"},{"key":"9533_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-018-9494-7","author":"C Ellermann","year":"2018","unstructured":"Ellermann, C., Wolfes, J., Puckhaber, D., B\u00f6geholz, N., Leitz, P., Lange, P. S., et al. (2018). Digitalis promotes ventricular arrhythmias in flecainide- and ranolazine-pretreated hearts. Cardiovascular Toxicology. https:\/\/doi.org\/10.1007\/s12012-018-9494-7 .","journal-title":"Cardiovascular Toxicology"},{"key":"9533_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.fjc.0000129581.81508.78","volume":"44","author":"P Milberg","year":"2004","unstructured":"Milberg, P., Ramtin, S., M\u00f6nnig, G., Osada, N., Wasmer, K., Breithardt, G., et al. (2004). Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block. Journal of Cardiovascular Pharmacology,44, 278\u2013286.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"9533_CR12","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1111\/1755-5922.12035","volume":"31","author":"G Frommeyer","year":"2013","unstructured":"Frommeyer, G., Milberg, P., Uphaus, T., Kaiser, D., Kaese, S., Breithardt, G., et al. (2013). Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation. Cardiovascular Therapeutics,31, e63\u2013e71.","journal-title":"Cardiovascular Therapeutics"},{"key":"9533_CR13","first-page":"62","volume":"1","author":"S Nattel","year":"2008","unstructured":"Nattel, S., Burstein, B., & Dobrev, D. (2008). Atrial remodeling and atrial fibrillation: Mechanisms and implications. Circulation: Arrhythmia and Electrophysiology,1, 62\u201373.","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"key":"9533_CR14","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1161\/01.CIR.103.15.2004","volume":"103","author":"L Hondeghem","year":"2001","unstructured":"Hondeghem, L., Carlsson, L., & Duker, G. (2001). Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation,103, 2004\u20132013.","journal-title":"Circulation"},{"key":"9533_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1540-8167.2007.00793.x","volume":"18","author":"P Milberg","year":"2007","unstructured":"Milberg, P., Hilker, E., Ramtin, S., Cakir, Y., Stypmann, J., Engelen, M. A., et al. (2007). Proarrhythmia as a class effect of quinolones: Increased dispersion of repolarization and triangulation of action potential predict torsades de pointes. Journal of Cardiovascular Electrophysiology,18, 647\u2013654.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"9533_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00395-003-0409-8","volume":"98","author":"D Dobrev","year":"2003","unstructured":"Dobrev, D., & Ravens, U. (2003). Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Research in Cardiology,98, 137\u2013148.","journal-title":"Basic Research in Cardiology"},{"key":"9533_CR17","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1161\/01.CIR.0000145155.60288.71","volume":"110","author":"E Wettwer","year":"2004","unstructured":"Wettwer, E., H\u00e1la, O., Christ, T., Heubach, F., Jr., Dobrev, D., Knaut, M., et al. (2004). Role of I Kur in controlling action potential shape and contractility in the human atrium: Influence of chronic atrial fibrillation. Circulation,110, 2299\u20132306.","journal-title":"Circulation"},{"key":"9533_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ijcard.2016.11.251","volume":"228","author":"G Frommeyer","year":"2017","unstructured":"Frommeyer, G., Kohnke, A., Ellermann, C., Dechering, D. G., Kochh\u00e4user, S., Pott, C., et al. (2017). Experimental evidence for a severe proarrhythmic potential of levosimendan. International Journal of Cardiology,228, 583\u2013587.","journal-title":"International Journal of Cardiology"},{"key":"9533_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2165\/00003088-200847080-00002","volume":"47","author":"S Vaidyanathan","year":"2008","unstructured":"Vaidyanathan, S., Jarugula, V., Dieterich, H. A., Howard, D., & Dole, W. P. (2008). Clinical pharmacokinetics and pharmacodynamics of aliskiren. Clinical Pharmacokinetics,47, 515\u2013531.","journal-title":"Clinical Pharmacokinetics"},{"key":"9533_CR20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1365-2125.2006.02696.x","volume":"62","author":"S Vaidyanathan","year":"2006","unstructured":"Vaidyanathan, S., Jermany, J., Yeh, C., Bizot, M. N., & Camisasca, R. (2006). Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects. British Journal of Clinical Pharmacology,62, 690\u2013698.","journal-title":"British Journal of Clinical Pharmacology"},{"key":"9533_CR21","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1177\/0091270008323258","volume":"48","author":"S Vaidyanathan","year":"2008","unstructured":"Vaidyanathan, S., Camenisch, G., Schuetz, H., Reynolds, C., Yeh, C. M., Bizot, M. N., et al. (2008). Pharmacokinetics of the oral direct renin inhibitor aliskiren in combination with digoxin, atorvastatin, and ketoconazole in healthy subjects: The role of P-glycoprotein in the disposition of aliskiren. Journal of Clinical Pharmacology,48, 1323\u20131338.","journal-title":"Journal of Clinical Pharmacology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-019-09533-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-019-09533-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-019-09533-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T09:05:22Z","timestamp":1721379922000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-019-09533-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["9533"],"URL":"https:\/\/doi.org\/10.1007\/s12012-019-09533-w","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"type":"print","value":"1530-7905"},{"type":"electronic","value":"1559-0259"}],"subject":[],"published":{"date-parts":[[2019,6,7]]},"assertion":[{"value":"7 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors report no relationships that could be construed as a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution at which the studies were conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}